BPC-157 vs Exenatide
Overview
BPC-157 is primarily a healing & recovery peptide, while Exenatide is used for weight management & metabolic.
This page compares BPC-157 and Exenatide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| BPC-157 | Exenatide | |
|---|---|---|
| Category | Healing & Recovery | Weight Management & Metabolic |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 250-500 mcg | 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) |
| Frequency | daily | Twice daily (Byetta) or once weekly (Bydureon) |
| Reported benefits | Accelerated wound healing, tendon and ligament repair, gut health improvement, reduced inflammation, neuroprotective effects | Glycemic control (HbA1c reduction 0.8–1.9 percentage points), modest body weight reduction (2–4 kg), low intrinsic hypoglycemia risk, modest systolic blood pressure reduction, cardiovascular non-inferiority established in EXSCEL |
| Reported side effects | Generally well-tolerated. Rare: injection site reactions, mild fatigue | Nausea, vomiting, diarrhea, injection site reactions, hypoglycemia (when co-administered with sulfonylureas), rare acute pancreatitis, rare acute kidney injury |
Key differences
Primary use. BPC-157 is categorised under Healing & Recovery, while Exenatide falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. BPC-157: not FDA-approved; compounding permitted with a prescription as of April 2026. Exenatide: FDA-approved.
Dosing. BPC-157 is typically dosed at 250-500 mcg (daily). Exenatide is typically dosed at 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) (Twice daily (Byetta) or once weekly (Bydureon)).
Can you stack them?
Some protocols combine peptides, but stacking BPC-157 and Exenatide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between BPC-157 and Exenatide?
- BPC-157 is primarily a healing & recovery peptide, while Exenatide is used for weight management & metabolic. BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Exenatide is FDA-approved for one or more indications.
- What is BPC-157 used for?
- Healing & recovery, gut health.
- What is Exenatide used for?
- FDA-approved GLP-1 receptor agonist for type 2 diabetes; the first incretin mimetic approved in the US.
- Can you take BPC-157 and Exenatide together?
- Some users combine peptides within a single protocol, but stacking BPC-157 and Exenatide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is BPC-157 or Exenatide FDA-approved?
- BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026). Exenatide is FDA-approved for one or more indications.